RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice

scientific article

RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/AJPGI.00329.2013
P698PubMed publication ID24875103
P5875ResearchGate publication ID262788311

P50authorHans HaunerQ21033707
Hannelore DanielQ1575859
P2093author name stringThomas Skurk
Tamara Zietek
Ramona Pais
P2860cites workAssociation of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).Q46818578
Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice.Q47214393
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTESQ24304260
The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasisQ24319758
Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1Q24682766
G-protein-coupled receptors in intestinal chemosensationQ26828554
The role of SGLT1 and GLUT2 in intestinal glucose transport and sensingQ27319522
Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophilsQ28205971
Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2Q28577695
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2Q28592795
Role of leptin in the regulation of glucagon-like peptide-1 secretionQ28609244
The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat.Q31725223
Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptidesQ33788748
Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestineQ33865081
Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetesQ34319292
The biology of incretin hormonesQ34499706
Sugar absorption in the intestine: the role of GLUT2.Q34656042
Terminal arteriolar network structure/function and plasma cytokine levels in db/db and ob/ob mouse skeletal muscleQ34842420
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.Q34857481
Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptorQ34991604
Enhancing Incretin Action for the Treatment of Type 2 DiabetesQ35545683
Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretionQ35612377
Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8Q36362602
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of actionQ36751470
Induction of intestinal epithelial proliferation by glucagon-like peptide 2.Q37449481
Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP.Q39796503
CCL5 promotes macrophage recruitment and survival in human adipose tissueQ39932026
Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell lineQ40104293
Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinasesQ40215541
Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathwaysQ40584252
Morbidly obese human subjects have increased peripheral blood CD4+ T cells with skewing toward a Treg- and Th2-dominated phenotype.Q40666702
Glucose-sensing in glucagon-like peptide-1-secreting cellsQ40708590
A human cellular model for studying the regulation of glucagon-like peptide-1 secretionQ40779469
Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist.Q41229926
Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?Q41909650
Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cellsQ42087161
Expression and secretion of RANTES (CCL5) in human adipocytes in response to immunological stimuli and hypoxiaQ42443891
Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitisQ42476082
Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in miceQ43266171
Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetesQ44280561
P433issue3
P921main subjectinsulin secretion involved in cellular response to glucose stimulusQ21108800
P304page(s)G330-7
P577publication date2014-05-29
P1433published inAmerican Journal of Physiology - Gastrointestinal and Liver PhysiologyQ15765756
P1476titleRANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice
P478volume307

Reverse relations

cites work (P2860)
Q26797335DPP4 in Diabetes
Q89442824Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function
Q26752511Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1
Q92799597Insights on the Role of Putative Muscle-Derived Factors on Pancreatic Beta Cell Function
Q26765259Stimulation of incretin secreting cells

Search more.